ZA896628B - Recombinant fusion proteins for altering hormone secretion - Google Patents

Recombinant fusion proteins for altering hormone secretion

Info

Publication number
ZA896628B
ZA896628B ZA896628A ZA896628A ZA896628B ZA 896628 B ZA896628 B ZA 896628B ZA 896628 A ZA896628 A ZA 896628A ZA 896628 A ZA896628 A ZA 896628A ZA 896628 B ZA896628 B ZA 896628B
Authority
ZA
South Africa
Prior art keywords
fusion proteins
recombinant fusion
hormone secretion
altering
altering hormone
Prior art date
Application number
ZA896628A
Inventor
Scott C Chappel
C Chappel Scott
Noreen P Nugent
P Nugent Noreen
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ZA896628B publication Critical patent/ZA896628B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA896628A 1988-08-30 1989-08-30 Recombinant fusion proteins for altering hormone secretion ZA896628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24655888A 1988-08-30 1988-08-30

Publications (1)

Publication Number Publication Date
ZA896628B true ZA896628B (en) 1991-04-24

Family

ID=22931196

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896628A ZA896628B (en) 1988-08-30 1989-08-30 Recombinant fusion proteins for altering hormone secretion

Country Status (9)

Country Link
EP (1) EP0396653A1 (en)
JP (1) JPH03502584A (en)
AU (1) AU629237B2 (en)
DK (1) DK106590D0 (en)
FI (1) FI902151A0 (en)
GR (1) GR1000321B (en)
IL (1) IL91462A0 (en)
WO (1) WO1990002187A1 (en)
ZA (1) ZA896628B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
GB9101550D0 (en) * 1991-01-24 1991-03-06 Mastico Robert A Antigen-presenting chimaeric protein
JPH05339295A (en) * 1991-12-05 1993-12-21 Agency Of Ind Science & Technol Preparation of antibody
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
DK1035133T3 (en) * 1999-02-17 2005-05-02 Pfizer Prod Inc Fusion proteins comprising carriers that can induce a dual immune response
EP1303533A2 (en) 2000-05-05 2003-04-23 Aphton Corporation Chimeric peptide immunogens, their preparation and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
DE3584866D1 (en) * 1984-09-12 1992-01-23 Chiron Corp HYBRID PARTICLE IMMUNOGENES.
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
WO1986007383A1 (en) * 1985-06-04 1986-12-18 Biotechnology Research Partners, Ltd. Autoantigen vaccines
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides

Also Published As

Publication number Publication date
FI902151A0 (en) 1990-04-27
EP0396653A1 (en) 1990-11-14
AU629237B2 (en) 1992-10-01
WO1990002187A1 (en) 1990-03-08
DK106590A (en) 1990-04-30
GR890100540A (en) 1990-08-22
AU4076189A (en) 1990-03-23
GR1000321B (en) 1992-06-25
IL91462A0 (en) 1990-04-29
DK106590D0 (en) 1990-04-30
JPH03502584A (en) 1991-06-13

Similar Documents

Publication Publication Date Title
IL94243A0 (en) Fusion polypeptide and its preparation
GB8610551D0 (en) Polypeptide & protein derivatives
NZ209591A (en) Polypeptide growth hormone release factor analogues
GB9112553D0 (en) Fusion proteins
GB8416007D0 (en) Recombinant plasmid
ZA893792B (en) Polypeptide compounds
AU2092983A (en) Porcine growth hormone produced by recombinant dna technology
AU7034691A (en) Lipoprotein signal peptide fused to antigenic polypeptides
NZ228951A (en) 7-10 residue growth hormone releasing polypeptide
AU5882486A (en) Releasing desired peptides from fusion polypeptides using endopeptidases
ZA896628B (en) Recombinant fusion proteins for altering hormone secretion
AU6979287A (en) Fusion proteins
ZA931203B (en) A recombinant polypeptide
ZA898139B (en) Recombinant interleukin-2 hybrid proteins
IL86153A0 (en) Recombinant htlv-iii proteins and uses thereof
NZ224484A (en) Preparation of a fused polypeptide using beta-galactosidase to form an insoluble fusion protein
ZA901695B (en) Recombinant protein receptor
NZ230797A (en) Recombinant polypeptide having ovine growth hormone activity
PT86162A (en) Recombinant protein expression
IE881482L (en) Recombinant htlv-iii proteins
ZA901213B (en) Somatotropin binding protein
GB8913991D0 (en) Recombinant hybrid proteins
GB9007065D0 (en) Recombinant protein receptor
GB8820365D0 (en) Recombinant dna proteins
IL99507A0 (en) Recombinant immunoglobin preparations